Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chymotrypsinogen B pseudogene is a non-coding DNA sequence at the human locus ENSG00000240338. It is categorized as a pseudogene because it shares sequence homology with active chymotrypsinogen B genes, which encode serine proteases involved in digestion, but it does not produce a functional protein. While some pseudogenes have regulatory roles in gene expression or may serve as genetic markers, the chymotrypsinogen B pseudogene has no documented biological activity, therapeutic relevance, or disease association. It should not be considered a therapeutic target for pharmacological intervention. The term "pseudogene" indicates the locus does not encode a functional protein or serve as a typical drug target, receptor, transporter, or enzyme. "Chymotrypsinogen B" is a member of the serine protease family, but as a pseudogene, this variant is inactive. There is no evidence in literature supporting any canonical therapeutic or diagnostic use for chymotrypsinogen B pseudogene. For research on therapeutic targets, functional gene family members such as chymotrypsinogen A or B (protein-coding) should be considered instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chymotrypsinogen B pseudogene.